About SRIKAR Labs
SRIKAR Labs is a company based in Hyderabad (India). The company has 148 employees. SRIKAR Labs offers products and services including APIs and Contract Research and Manufacturing Services.
- Headquarter Hyderabad, India
- Employees 148
- SectorsHealthcare
- Email••••••••
- Social X Facebook
- Legal Name Srikar Laboratories Pvt. Ltd
- Date of Incorporation 23 Feb, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹72.62 Cr
FY 2025 · -10% YoY
- Net Profit₹3.55 Cr
FY 2025 · 5% margin
- EBITDA₹9.31 Cr
FY 2025 · 13% margin
- Employee Count148
Associated legal entities of SRIKAR Labs
SRIKAR Labs operates through Srikar Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srikar Laboratories Private Limited CIN U24100TG2011PTC072844 | Active | 23 Feb 2011 | Hyderabad, Telangana | ₹72.6 Cr | 148 | 4 | View details |
Products & Services of SRIKAR Labs
SRIKAR Labs offers a comprehensive portfolio of products and services, including APIs and Contract Research and Manufacturing Services.
Active pharmaceutical ingredients are manufactured and supplied by SRIKAR Labs in compliance with international regulations.
Contract research, process development, and manufacturing services are provided by SRIKAR Labs for global pharmaceutical programs.
Board of directors of Srikar Laboratories Private Limited (SRIKAR Labs)
Srikar Laboratories Private Limited is the primary company behind SRIKAR Labs. The board of Srikar Laboratories Private Limited currently have 4 directors; the longest-serving is Murali Krishnam Raju Vadlamudi, appointed in 2011. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murali Krishnam Raju Vadlamudi DIN 02304104 | Director | 23 Feb 2011 | 15 yrs 7 mo | Srikar Laboratories Private Limited |
| Satyanarayana Raju Kanteti DIN 00884094 | Director | 30 Nov 2020 | 5 yrs 10 mo | Srikar Laboratories Private Limited |
| Sandeep Reddy Veerlapally DIN 09507367 | Director | 19 Nov 2022 | 3 yrs 10 mo | Srikar Laboratories Private Limited |
| Vijender Medamoni DIN 01594109 | Managing Director | 04 Aug 2025 | 1 yr 2 mo | Srikar Laboratories Private Limited |
Financials of SRIKAR Labs
Figures of Srikar Laboratories Private Limited, the primary company behind SRIKAR Labs, for FY 2025. Revenue was ₹72.62 Cr (-10% year on year). Net profit was ₹3.55 Cr (5% margin). EBITDA was ₹9.31 Cr (13% margin). Revenue has grown at a compounded annual rate of +4% over three years and +9% over five years.
- ₹72.62 CrRevenue · FY 2025 · -10% YoY
- ₹3.55 CrNet profit · 5% margin
- ₹9.31 CrEBITDA · 13% margin
- ₹6.99 CrPaid-up capital
- 148Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Srikar Laboratories Private Limited are on its company page.
Detailed financial statements for SRIKAR Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to SRIKAR Labs
10 companies that operate in the same segment as SRIKAR Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SRIKAR Labs
SRIKAR Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
SRIKAR Labs has 148 employees.
The primary company behind SRIKAR Labs, Srikar Laboratories Private Limited, reported revenue of ₹72.62 Cr for FY 2025, down 10% year on year.
SRIKAR Labs is identified as a manufacturer of active pharmaceutical ingredients, with services extending to contract research and manufacturing that comply with international GMP standards. Operations are conducted at facilities in India, where FDA approvals have been obtained through adherence to quality and safety protocols. A commitment to sustainable development and high-quality supply of drug substances is demonstrated, supporting global health-care initiatives. Expertise in chemical process development and regulatory compliance is utilized to accelerate programs for Novel Chemical Entities, contributing to societal health advancements.
SRIKAR Labs offers APIs and Contract Research and Manufacturing Services.
SRIKAR Labs operates through Srikar Laboratories Private Limited.
The legal entities of SRIKAR Labs currently have 4 directors, including Murali Krishnam Raju Vadlamudi, Satyanarayana Raju Kanteti, Sandeep Reddy Veerlapally and others.